Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-085717
Filing Date
2023-03-30
Accepted
2023-03-30 16:51:32
Documents
5
Effectiveness Date
2023-03-30

Document Format Files

Seq Description Document Type Size
1 S-8 d479712ds8.htm S-8 48166
2 EX-5.1 d479712dex51.htm EX-5.1 7401
3 EX-23.1 d479712dex231.htm EX-23.1 1579
4 EX-FILING FEES d479712dexfilingfees.htm EX-FILING FEES 19799
5 GRAPHIC g479712g0329114807487.jpg GRAPHIC 2526
  Complete submission text file 0001193125-23-085717.txt   81687
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271001 | Film No.: 23781401
SIC: 2836 Biological Products, (No Diagnostic Substances)